Shandong Sinobioway Biomedicine Co., Ltd.

SZSE:002581.SZ

15.12 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q1
Revenue 102.313126.97783.80591.444129.18133.56475.60381.55187.884100.25887.38786.92191.467141.7682.56585.80955.06634.069101.886133.206134.83173.427126.174171.698199.116146.63147.15401.079231.066259.319270.952389.584317.873293.819257.604354.313182.89696.4896.94170.41674.76487.86186.09895.04372.22975.43774.54567.02269.67175.32973.32381.82162.25634.22168.07172.23757.10457.11860.715
Cost of Revenue 21.40524.13316.6519.64123.87925.29314.58212.02517.12219.21527.84923.20118.52427.84716.26321.48111.4984.67116.67620.20716.84520.94416.14520.42327.58126.57423.97653.44452.26968.11481.83792.99270.49569.00566.85483.71322.95359.70258.7144.14544.46554.72448.28955.59941.08739.82641.58140.35140.11740.35137.12544.8731.87217.21434.70239.19330.2128.51430.944
Gross Profit 80.908102.84467.15571.802105.301108.27161.0269.52670.76281.04359.53863.72172.943113.91366.30264.32943.56829.39985.209112.999117.985152.483110.029151.275171.535120.056123.173347.635178.796191.205189.116296.592247.378224.814190.75270.6159.94336.77838.23126.27230.29933.13737.80939.44431.14135.61132.96426.6729.55334.97836.19836.95130.38517.00733.36933.04526.89328.60329.771
Gross Profit Ratio 0.7910.810.8010.7850.8150.8110.8070.8530.8050.8080.6810.7330.7970.8040.8030.750.7910.8630.8360.8480.8750.8790.8720.8810.8610.8190.8370.8670.7740.7370.6980.7610.7780.7650.740.7640.8750.3810.3940.3730.4050.3770.4390.4150.4310.4720.4420.3980.4240.4640.4940.4520.4880.4970.490.4570.4710.5010.49
Reseach & Development Expenses 5.7585.7956.20821.0979.95820.4168.3287.6427.7456.7715.13117.7193.3618.9738.38512.07313.88111.02212.3214.2079.70720.37410.36622.3159.8756.5437.2250.01911.67116.348044.00300029.444010.909024.1570000000000000000000
General & Administrative Expenses 04.67435.42515.17253.94420.08927.98-10.51156.9775.88530.4681139.29316.29222.743-3.21534.71310.09534.7381.57623.0838.39423.779.82331.6923.20830.709-16.6325.45-4.79327.946-12.05922.033-1.58619.663-0.79812.801-2.814.34-11.3738.063-3.1775.052-13.4137.003-1.5995.625-10.2065.772-1.0075.878-8.74310.773-2.785.936-11.8116.7926.264.203
Selling & Marketing Expenses 081.34246.80674.88277.05486.57149.79159.05788.98383.95460.48365.39684.81127.60367.52689.20650.32381.2565.464125.363103.936113.74779.41140.07299.2387.12568.174104.73795.602111.74877.154106.532107.715111.55982.843107.35483.1144.1923.0053.4083.2573.1463.0944.912.8012.8352.6453.1672.5192.9931.9613.0661.7511.0492.0562.9632.3282.111.484
SG&A 81.65786.01682.23190.054130.998106.6677.77148.547145.96189.83990.95176.395124.103143.89490.26985.99185.03591.344100.202126.939127.019122.141103.181149.894130.92290.33498.88388.107121.052106.955105.194.474129.748109.973102.506106.55695.9141.3827.345-7.96511.321-0.0318.146-8.5039.8041.2378.27-7.0398.2911.9867.839-5.67812.524-1.7317.992-8.8489.128.375.687
Other Expenses 0-0.1761.101-18.323-0.978-0.6520.35748.699-24.81323.454-1.6526.299-0.222-0.484-0.077-6.214-0.1160.655-0.428-1.768-0.036-0.113-0.32114.936-1.0570.5290.078-4.4311.9130.3021.1224.8161.3718.4990.8581.6773.2160.0810-0.1850.0411.5450.002-0.1540.050.9850.0020.3540.15-0.1790.0020.2110.311-0.0140.3760.216-0.1620.355-0.099
Operating Expenses 87.415105.68789.708160.174115.362151.07186.456104.888128.892120.06494.431132.865110.019166.85998.37913198.264120.196110.911172.42136.855158.627114.161203.981141.292116.07498.963136.523122.453137.559106.716165.918131.427136.473104.055156.68896.5711.6138.48914.50111.8668.5319.02313.44110.61311.0798.71912.268.86611.4938.47214.20212.8765.9498.66810.6519.128.375.687
Operating Income -6.5073.691-27.948-337.97695.082-29.311-21.146-38.939-58.1377.323-34.893-80.923207.959125.16820.879-74.066-19.322-57.491-44.7818.2325.66542.402-7.29-114.96517.837-78.69388.576157.101105.633110.64491.791146.817129.34780.23786.779117.32263.23628.35831.81714.37821.23827.32731.34426.19822.91827.03426.18320.77521.47330.65128.18625.217.48311.12924.42722.32917.4632024.108
Operating Income Ratio -0.0640.029-0.333-3.6960.736-0.219-0.28-0.477-0.6610.771-0.399-0.9312.2740.8830.253-0.863-0.351-1.687-0.440.1370.190.244-0.058-0.670.09-0.5370.6020.3920.4570.4270.3390.3770.4070.2730.3370.3310.3460.2940.3280.2040.2840.3110.3640.2760.3170.3580.3510.310.3080.4070.3840.3080.2810.3250.3590.3090.3060.350.397
Total Other Income Expenses Net 57.57-0.1631.101-17.96-0.978-0.652-0.309-19.53495.534-0.70942.2036.299-0.222-0.484-0.077-6.214-0.1160.655-0.428-1.768-0.036-0.113-0.321-1.947-1.0570.5290.078-17.1251.9130.2961.1222.741.2851.8890.8581.5913.2160.0810.417-0.185-1.3751.5450.002-0.1540.050.9850.0020.3340.15-0.1790.0020.2110.311-0.0140.3760.216-0.1620.355-0.099
Income Before Tax 51.0643.528-26.847-355.93694.104-29.963-21.455-58.47237.40426.4837.31-74.624207.737124.68420.801-80.28-19.438-56.836-45.20916.46225.62942.288-7.611-116.28316.78-78.16388.653152.73107.546110.9492.913149.557130.63288.73587.636118.91366.45228.4431.81714.19321.27928.87331.34626.04422.96928.01926.18521.10921.62430.47328.18825.41117.79411.11524.80322.54517.30120.35524.009
Income Before Tax Ratio 0.4990.028-0.32-3.8920.728-0.224-0.284-0.7170.4260.2640.084-0.8592.2710.880.252-0.936-0.353-1.668-0.4440.1240.190.244-0.06-0.6770.084-0.5330.6020.3810.4650.4280.3430.3840.4110.3020.340.3360.3630.2950.3280.2020.2850.3290.3640.2740.3180.3710.3510.3150.310.4050.3840.3110.2860.3250.3640.3120.3030.3560.395
Income Tax Expense 2.2471.2870.2084.7274.723-0.488-0.07610.46-1.4172.0112.539-2.601-0.8396.434-3.08514.704-3.843-17.9063.4590.917-0.3770.9752.168-6.1148.6670.2116.45136.7949.82811.82514.773-8.48818.78615.99613.75216.110.9484.2294.6792.1543.0084.2264.8263.7043.3054.273.9013.083.2444.5714.2284.0572.7291.643.724.5262.7512.8713.807
Net Income 44.241-1.911-27.704-362.17283.471-32.251-21.379-68.93240.49422.1224.77-76.451209.532113.5324.391-89.94-13.642-29.532-62.82114.06423.66438.582-12.927-108.3826.999-76.77982.373116.09995.5299.54377.249147.791116.96174.62378.32104.258.74824.2127.13912.0418.27224.64726.5222.3419.66423.7522.28418.02918.3825.90223.9621.35315.0659.47521.08318.01914.55117.48420.202
Net Income Ratio 0.432-0.015-0.331-3.9610.646-0.241-0.283-0.8450.4610.2210.055-0.882.2910.8010.295-1.048-0.248-0.867-0.6170.1060.1760.222-0.102-0.6310.035-0.5240.560.2890.4130.3840.2850.3790.3680.2540.3040.2940.3210.2510.280.1710.2440.2810.3080.2350.2720.3150.2990.2690.2640.3440.3270.2610.2420.2770.310.2490.2550.3060.333
EPS 0.067-0.003-0.042-0.550.13-0.049-0.032-0.10.0620.0340.007-0.120.320.170.037-0.14-0.021-0.045-0.0950.0210.0360.059-0.02-0.160.011-0.120.120.170.140.150.120.230.180.110.120.370.160.0850.0710.0430.0660.0880.0950.080.070.0860.080.0640.0650.0920.0850.0760.0540.0450.10.0860.0690.0830.096
EPS Diluted 0.067-0.003-0.042-0.550.13-0.049-0.032-0.10.0620.0340.007-0.120.320.170.037-0.14-0.021-0.045-0.0950.0210.0360.059-0.02-0.160.011-0.120.120.170.140.150.120.230.180.110.120.370.160.0850.0710.0430.0660.0880.0950.080.070.0860.080.0640.0650.0920.0850.0760.0540.0450.10.0860.0690.0830.096
EBITDA 51.0644.044-23.62-347.301113.667-7.5751.46153.931-169.81872.667-36.784-44.262-271.073181.051-17.9144.678-34.644-64.716-25.701-27.045-18.8772.18411.04391.9630.24325.75324.21284.63757.285121.45286.376160.622115.951102.54289.248133.28463.37325.16554.19811.77147.38724.60628.78627.38220.52824.16124.24529.49620.36130.93528.20826.52217.50911.62224.70124.80419.7620.30223.858
EBITDA Ratio 0.4990.032-0.282-0.7560.691-0.051-0.3442.066-1.9710.725-0.4214.711-2.9771.278-0.3880.521-0.982-1.9-0.2520.969-0.140.452-0.0330.5360.1830.1760.1620.7480.2480.4660.3190.4290.3790.3160.3460.3880.3340.260.3130.170.2380.2820.3360.2880.2820.320.3350.4390.2920.4090.3850.3240.2830.340.3630.3420.3460.3550.393